SecurMed UK
SecurMed UK operates the UKNI Medicines Verification System, a non-profit digital platform designated under the Falsified Medicines Directive to verify prescription medicines authenticity for UK and Northern Ireland pharmacies, hospitals, wholesalers and GPs, funded by pharmaceutical manufacturers through mandatory MAH fees.
- Company typePrivate
- Founded2019
- HeadquartersAbingdon, United Kingdom
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What SecurMed UK does
SecurMed UK is a non-profit organisation designated under the European Falsified Medicines Directive (2011/62/EU) and Delegated Regulation 2016/161 to operate the UKNI Medicines Verification System (UK MVS). The company was established in 2019 (with founding activities dating to 2016) and is registered in England under company number 10276927, with primary offices in Abingdon and Belfast. Its core product is the UKNI MVS, a digital verification platform that allows pharmacies, hospitals, wholesalers and GP practices to verify unique identifiers on prescription medicine packs against national and European repositories, and to decommission packs upon patient supply. The platform is connected to the European Medicines Verification System (EMVS) European Hub, enabling cross-border medicines verification across the UK and Northern Ireland supply chain.
The technical infrastructure is delivered in partnership with Arvato Systems, which provides the IT Solutions Developers Toolkit (SDK), sandbox environment and technical helpdesk for the 42+ approved IT software suppliers building integrations to the system. Supporting capabilities include an Alert Management System (NMVS Alerts AMS) for investigating verification failures, Scanner Check Packs for equipment validation, digital certificate management for secure access, and web-service APIs documented through the Arvato SDK portal.
SecurMed UK earns revenue exclusively from Marketing Authorisation Holders (MAHs) under a mandatory fee structure: a one-time £35,000 set-up fee and a £20,000 annual operational fee per MAH legal entity, with micro-MAH waivers available. End-user organisations (pharmacies, hospitals, GPs, wholesalers) access the system at no charge through certified software providers. The business is governed under oversight from the MHRA and DHSC, with industry partnerships across ABPI, BGMA, HDA UK, and technology partnerships with Arvato Systems, Solidsoft Reply, and the European Medicines Verification Organisation (EMVO).
SecurMed UK firmographics
Firmographics- Name
- SecurMed UK
- Legal name
- SecurMed UK
- Website
- https://securmed.org.uk
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- SecurMed UK operates the UKNI Medicines Verification System, a non-profit digital platform designated under the Falsified Medicines Directive to verify prescription medicines authenticity for UK and Northern Ireland pharmacies, hospitals, wholesalers and GPs, funded by pharmaceutical manufacturers through mandatory MAH fees.
- Ownership category
- akta.pro rank
SecurMed UK industry classification
Industry- Product category
- Pharmaceutical Medicines Verification
- NAICS
- Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- ePrescribing & Medication Workflow Platforms (EPCS, formulary, prior auth, med history) (HLALAIAD)
Keywords
Where SecurMed UK is headquartered
LocationHeadquarters
- HQ city
- Abingdon
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
SecurMed UK business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Operations, Personnel, Marketing or Sales, Others
Revenue model
- MAH Set-Up Fees: One-time set-up fee of GBP £35,000 payable upon MAH registration. Each MAH legal entity must pay separately, so companies with multiple MAH entities pay fees for each.
- Annual MAH Operational Fees: Annual operational fee of GBP £20,000 for 2019 (likely adjusted for subsequent years) payable by each MAH legal entity. Payment required within 30 days of invoice.
- End User Access (No Cost): No fees charged to end users (pharmacies, hospitals, wholesalers, GPs). The system is funded entirely by pharmaceutical manufacturers and parallel distributors (MAHs), as mandated under the Falsified Medicines Directive.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | MAH Set-Up Fee |
| Subscription | Annual | Annual MAH Operational Fee |
| Subscription | Annual | Micro MAH Fee Waiver |
| Freemium | Annual | End User Access |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels4 records
SecurMed UK product offering
Product offeringCore offering
SecurMed UK operates the UKNI Medicines Verification System (UK MVS), a national digital verification platform that authenticates prescription medicine packs against the European Medicines Verification System to prevent falsified medicines from entering the UK supply chain. The service is delivered to Marketing Authorisation Holders (MAHs), pharmacies, hospitals, wholesalers, and GP practices, with end users accessing verification and decommissioning capabilities through approved IT software suppliers integrated via the Arvato Systems SDK.
Product overview
SecurMed UK operates the UKNI Medicines Verification System (UK MVS) — a core platform for verifying prescription medicines under the Falsified Medicines Directive. The system consists of the main UKNI MVS platform for medicine verification and decommissioning, supplemented by the NMVS Alerts AMS for alert management, Scanner Check Packs for equipment verification, and digital certificate management for secure access. The IT Solutions Developers Toolkit (SDK) enables third-party software providers to build integrations with the UK MVS. End users (pharmacies, hospitals, GPs, wholesalers) and Marketing Authorisation Holders (MAHs) register through separate portals and pay applicable fees (Set-Up Fee of £35,000 and Annual Operational Fee of £20,000 for MAHs).
Differentiator
Problem solved
Functional benefit
Products and services
- UKNI Medicines Verification System (UK MVS) The core national medicines verification system for the UK that enables verification and authentication of prescription medicines against falsification, as required under the Falsified Medicines Directive. The system verifies unique identifiers on medicine packs and manages decommissioning at the point of supply to patients. It is used by MAHs to upload pack data, and by pharmacies, hospitals, wholesalers and GPs to verify medicines.
- NMVS Alerts AMS (Alert Management System) Alert Management System for the NMVS that enables stakeholders to manage, investigate, and report alerts when medicines verification fails or suspicious products are detected. Used by end users and MAHs to progress the analysis of alerts generated by the UK MVS.
- Scanner Check Packs Verification tool allowing end users to test their scanner and software configuration against the UK MVS to ensure proper setup before scanning actual medicine packs. Used by end-user organisations during onboarding and configuration validation.
- UKNI MVS Digital Certificates Digital certificates with 2-year validity required for accessing the UKNI MVS. Users receive system-generated reminders at 60 days and 30 days before expiry and must download new certificates via the Certificate Portal. Required by all end users to authenticate system access.
- End User Registration System Registration process and portal for organisations that handle or dispense prescription medicines in Northern Ireland, including Community Pharmacies, Hospital Pharmacies, GP Practices, Wholesalers, and Healthcare Institutions. Required to obtain access to the UKNI MVS.
- IT Solutions Developers Toolkit (SDK) Software development toolkit provided by Arvato Systems that enables IT software providers to create web-services interface connections to the UK MVS. The SDK includes technical documentation, a sandbox test environment with test serial number creation, sample code snippets, test plans and reports, a pre-release baseline testing procedure, and a technical helpdesk service. Used by approved software suppliers.
Quantifiable outcome
- Connected to European Hub (EMVS) since 31st October 2018
Companies that use SecurMed UK
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
SecurMed UK technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration48 records
Feature4 records
SecurMed UK partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and supporting.
- Arvato SystemscoreArvato Systems is the IT Service Provider for the UK Medicines Verification System, providing the technical infrastructure, Developers Toolkit (SDK), sandbox environment, and technical helpdesk services for software suppliers connecting to the UK MVS.
- European Medicines Verification Organisation (EMVO)coreSecurMed UK is connected to the European Hub operated by EMVO, enabling UK pharmacies, hospitals, and wholesalers to verify medicines against the pan-European EMVS database.
- Medicines and Healthcare products Regulatory Agency (MHRA)coreMHRA is the UK competent authority that designated SecurMed UK to operate the UKNI MVS and provides guidance on FMD implementation and compliance.
- Department of Health and Social Care (DHSC)coreDHSC, along with MHRA, confirmed FMD requirements for the UK and designated SecurMed UK as the UKNI Medicines Verification Organisation.
- NHS DigitalsupportingNHS Digital developed guidance toolkits for healthcare professionals implementing FMD, including GP Practice toolkit and falsified medicines implementation resources.
- ABPI (Association of the British Pharmaceutical Industry)supportingIndustry association providing guidance for manufacturers and MAHs on FMD compliance.
- BGMA (British Generic Manufacturers Association)supportingIndustry association representing generic medicine manufacturers in the UK.
- HDA UK (Healthcare Distribution Association)supportingIndustry association providing guidance for wholesalers on FMD compliance.
- Solidsoft ReplysupportingProvides the EU Hub infrastructure. Live status of all Solidsoft Reply Countries available at status.nmvo.eu.
Scale indicators3 records
Recent moves6 records
Expansion highlights4 records
SecurMed UK competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
SecurMed UK social profiles
Digital presenceSecurMed UK compliance and trust
Trust signalCompliance2 records
SecurMed UK financial estimates
Financial estimateRevenue estimate
Valuation estimate
SecurMed UK leadership team
Management profileNumber of profiles
SecurMed UK funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SecurMed UK M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SecurMed UK
What does SecurMed UK do?
SecurMed UK operates the UKNI Medicines Verification System (UK MVS), a national digital verification platform that authenticates prescription medicine packs against the European Medicines Verification System to prevent falsified medicines from entering the UK supply chain. The service is delivered to Marketing Authorisation Holders (MAHs), pharmacies, hospitals, wholesalers, and GP practices, with end users accessing verification and decommissioning capabilities through approved IT software suppliers integrated via the Arvato Systems SDK.
Is SecurMed UK a public or private company?
SecurMed UK is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was SecurMed UK founded?
SecurMed UK was founded in 2019. It employs 1 to 10 people.
Where is SecurMed UK based?
SecurMed UK is headquartered in Abingdon, United Kingdom, in the Europe region.
How does SecurMed UK make money?
Three revenue lines are on record. MAH Set-Up Fees are the primary driver. The others are annual MAH Operational Fees and end User Access (No Cost).
Does SecurMed UK have an API?
Yes. SecurMed UK, through IT Service Provider Arvato Systems, provides an IT Solutions Developers Toolkit (SDK) to IT software providers and departments to enable them to create interface (web-services) connections to the UK MVS. The SDK contains a full set of technical documentation, a Sandbox test environment with test serial number creation, sample code snippets, test plans and reports, a pre-release baseline testing procedure, and a technical helpdesk service. Software suppliers can register for the SDK at https://sws-nmvs.eu. Developer documentation is at sws-nmvs.eu.
What industry is SecurMed UK in?
SecurMed UK's product category is Pharmaceutical Medicines Verification. Its primary akta.pro industry code is HLALAIAD, ePrescribing & Medication Workflow Platforms (EPCS, formulary, prior auth, med history). Its NAICS code is 6215 and its SIC code is 8000.